CSIMarket
 
Castle Biosciences Inc   (CSTL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Castle Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the forth quarter 2023, Castle Biosciences Inc 's inventory turnover ratio sequentially decreased to 7.39 in the fourth quarter 2023, unsurprisingly, as the Castle Biosciences Inc markets continue to deteriorate, and CSTL's faces growing challenges to bring down its inventories. Castle Biosciences Inc 's average inventory processing period in the Dec 31 2023 quarter, has increased to 49 days, from 37 days, in the Sep 30 2023 quarter.

Within Healthcare sector 34 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 183 in the third quarter 2023, to 261.

CSTL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Castle Biosciences Inc Market Share?

What is Inventory Turnover Ratio?


CSTL Inventory Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Inventory Growth 99.55 % 51.74 % 81.9 % 92.34 % 96.93 %
Y / Y Cost of Sales Growth -30.47 % 47.27 % 86.04 % 121.49 % 297.07 %
Inventory Turnover Ratio (TTM) 7.39 9.89 10.16 10.64 10.7
CSTL's Total Ranking # 261 # 183 # 121 # 333 # 202
Average inventory processing period 49 37 36 34 34
Seq. Inventory Growth 37.67 % -5.75 % 35.42 % 13.57 % 4.68 %
Seq. Cost of Sales Growth 9.75 % 2.36 % 8.6 % -43.02 % 132.47 %



Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 35
Overall Market # 261

Inventory Turnover Ratio Statistics
High Average Low
10.7 7.73 3.63
(Dec 31 2022)   (Dec 31 2019)




Financial Statements
Castle Biosciences Inc 's Inventories $ 8 Millions Visit CSTL's Balance sheet
Castle Biosciences Inc 's Cost of Revenues TTM $ 45 Millions Visit CSTL's Income Statement
What are CSTL's Sales? Visit CSTL's Sales by Segment

Other Inventory Turnover Ratios
Castle Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CSTL's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CSTL's Competitors
Inventory Turnover Ratio for CSTL's Suppliers
Inventory Turnover Ratio for CSTL's Customers

You may also want to know
CSTL's Sales Growth Rates CSTL's Pe Price to earnings ratio CSTL's Receivables Turnover Ratio CSTL's Stock Quote
CSTL's Net Income Growth Rates CSTL's Ps Price to Sales ratio CSTL's Sales per Employee CSTL's Asset Turnover Ratio
CSTL's Net Margin CSTL's Pb Price to Book ratio CSTL's Financial Strength Ratios CSTL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
The Oncology Institute Inc   15.00 $ 181.017  Millions$ 12  Millions
Semler Scientific Inc   14.92 $ 6.984  Millions$ 0  Millions
Natera inc   14.16 $ 588.564  Millions$ 42  Millions
Aspira Women s Health Inc   14.13 $ 3.892  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   13.01 $ 14.796  Millions$ 1  Millions
Option Care Health Inc   12.80 $ 3,321.000  Millions$ 259  Millions
Eton Pharmaceuticals Inc   12.44 $ 10.000  Millions$ 1  Millions
Irhythm Technologies Inc   10.94 $ 160.000  Millions$ 15  Millions
Lantheus Holdings Inc   10.93 $ 586.000  Millions$ 54  Millions
Sotera Health Company  10.78 $ 472.000  Millions$ 44  Millions
Genedx Holdings Corp   10.67 $ 112.000  Millions$ 10  Millions
Infusystem Holdings Inc   10.51 $ 62.676  Millions$ 6  Millions
Myriad Genetics Inc   10.34 $ 236.200  Millions$ 23  Millions
Earth Science Tech Inc   10.26 $ 1.843  Millions$ 0  Millions
23andme Holding Co  10.20 $ 134.395  Millions$ 13  Millions
Prosomnus Inc   9.48 $ 13.641  Millions$ 1  Millions
Moderna Inc   8.79 $ 4,693.000  Millions$ 534  Millions
Collegium Pharmaceutical Inc   8.76 $ 274.730  Millions$ 31  Millions
National Vision Holdings Inc   8.26 $ 1,000.910  Millions$ 121  Millions
Novavax inc  8.14 $ 343.768  Millions$ 42  Millions
Bionexus Gene Lab Corp  7.83 $ 8.441  Millions$ 1  Millions
Charles River Laboratories International inc   7.52 $ 2,295.983  Millions$ 305  Millions
Castle Biosciences Inc   7.39 $ 44.982  Millions$ 6  Millions
Alimera Sciences Inc   7.34 $ 10.837  Millions$ 1  Millions
Hims and Hers Health Inc   7.25 $ 157.000  Millions$ 22  Millions
Owens and Minor inc  7.06 $ 8,208.000  Millions$ 1,163  Millions
Kewaunee Scientific Corporation  6.88 $ 150.625  Millions$ 22  Millions
Prophase Labs Inc   6.66 $ 28.000  Millions$ 4  Millions
Hutchmed china Limited  6.61 $ 331.984  Millions$ 50  Millions
Cardiff Lexington Corporation  6.59 $ 3.561  Millions$ 1  Millions

Date modified: 2024-02-29T17:00:32+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com